Zhu, T., Hsu, J. C., Guo, J., Chen, W., Cai, W., & Wang, K. (2023). Radionuclide-based theranostics — a promising strategy for lung cancer. European Journal of Nuclear Medicine & Molecular Imaging, 50(8), 2353. https://doi.org/10.1007/s00259-023-06174-8
Chicago Style (17th ed.) CitationZhu, Tianxing, Jessica C. Hsu, Jingpei Guo, Weiyu Chen, Weibo Cai, and Kai Wang. "Radionuclide-based Theranostics — a Promising Strategy for Lung Cancer." European Journal of Nuclear Medicine & Molecular Imaging 50, no. 8 (2023): 2353. https://doi.org/10.1007/s00259-023-06174-8.
MLA (9th ed.) CitationZhu, Tianxing, et al. "Radionuclide-based Theranostics — a Promising Strategy for Lung Cancer." European Journal of Nuclear Medicine & Molecular Imaging, vol. 50, no. 8, 2023, p. 2353, https://doi.org/10.1007/s00259-023-06174-8.